Steroid Reduces the Risk for Major Adverse Kidney Events in IgA Nephropathy
A reduced-dose steroid regimen in high-risk IgaN may offer the best balance of risks vs benefits, an investigator stated.
Diagnosis & Disease Information
Chlorthalidone Safe, Effective for Treating Hypertension in Advanced CKD
In a study of patients with stage 4 chronic kidney disease and poorly controlled blood pressure, chlorthalidone significantly decreased systolic blood pressure compared with placebo.
Earlier Dialysis Transition May Decrease Survival
In 2020, nearly 72% of patients in a US study initiated dialysis at an eGFR of 10 mL/min/1.73 m2 or higher.
Predictors of AKI Related to Immune Checkpoint Inhibitor Use Identified
Lower baseline kidney function and proton pump inhibitor use increased the risk for acute kidney injury associated with immune checkpoint inhibitor therapy.
Metabolic Acidosis in CKD Linked to Higher Kidney Stone Risk
Metabolic acidosis was defined as serum bicarbonate values of 12 or higher but less than 22 mEq/L.
Blood Transfusions in Kidney Transplant Recipients Raise VTE Risk
Receipt of any RBC transfusion was significantly associated with increased risk for venous thromboembolism.
Multiple Comorbidities in CKD Up Risks for Major Cardiovascular Events
Multimorbidity is more common in patients with chronic kidney disease (CKD) than any other long-term condition, according to investigators.
SGLT2 Inhibitors Appear Protective in CKD, Kidney Transplantation
SGLT2 inhibitors are associated with an initial dip in eGFR, so nephrologists need to monitor kidney function.
SHPT Treatment Tied With Lower Dementia Risk
Elevated parathyroid hormone has been reported as a potential risk factor for cognitive impairment.
COVID-19 Survivors Face Greater Burden of AKI, CKD
Patients who survive the first 30 days of COVID-19 are more likely to have acute kidney injury and chronic kidney disease compared with those who do not contract the disease.
- Loading...
Loading...
Next post in Kidney Week 2021
Loading... 
Loading...